Method for determining Tween-60 content in pharmaceutical preparation by LC-CAD (liquid chromatography-computer aided design) method
By reverse phase liquid chromatography combined with CAD detector, the rapid and accurate determination of Tween 60 content in drug preparations was solved, and accurate analysis of Tween 60 in foam preparations was achieved, ensuring generic drugs and reference comparison Quality consistency of the preparation.
Patent Information
- Application Number
- CN202411173263.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-11-08
AI Technical Summary
The prior art lacks a fast, accurate and sensitive method for the Tween 60 content in pharmaceutical preparations, especially in foaming agents, which are difficult to meet the quality consistency of generic drugs and reference preparations.
Reverse phase liquid chromatography combined with CAD detectors is used to optimize the column, mobile phase and gradient elution procedures, combined with HPLC or UPLC technology to achieve accurate quantitative analysis of Tween 60.
This method can quickly and accurately determine the Tween 60 content in foam preparations, meet the requirements of pharmacopoeia and ICH, and provides a detection method suitable for a variety of concentrations and proportions, ensuring the safety and quality consistency of generic drugs. .
Smart Images

Figure CN118914439A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a method for determining the content of Tween 60 in a pharmaceutical preparation, and in particular to a method for determining the content of Tween 60 in a pharmaceutical preparation by using a liquid chromatography-electrospray type detector coupling technology. Background Art
[0002] In recent years, the CDE has issued a number of technical guidelines for generic drug research, which clearly point out that the types of excipients Q1 and the amounts Q2 of generic drugs and reference preparations should be basically the same, which helps to ensure the consistency of the quality of generic drugs and reference preparations. Generic drug developers may obtain the composition of the reference preparation prescription through information retrieval, but the amounts of most excipients in the reference preparation cannot be obtained, and reverse engineering is needed to measure the amount of the excipient in the reference preparation, such as Tween 60.
[0003] Tween 60, also known as polysorbate 60, sorbitan monostearate, polyoxyethylene sorbitan monostearate, molecular formula C 64 H 126 O 26 , CAS No. 9005-67-8, is a series of partial fatty acid esters of polyoxyethylene sorbitan, which is obtained by connecting 20 mol of oxyethylene units to the parent nucleus of 1 mol of sorbitan and esterifying with 1 mol of fatty acid. Tween 60 is a nonionic surfactant with significant resistance to electrolytes and strong hydrophilicity. It is widely used in the pharmaceutical, cosmetic, food and other industries. In the pharmaceutical field, it is commonly found in liquid, semi-solid and solid preparations, and can be used as an emulsifier, solubilizer, wetting agent, dispersant and stabilizer.
[0004] However, due to the complex chemical composition of Tween 60, the amount used in preparations is often small (usually less than 1% in foams), and the foams contain both raw materials and a variety of different excipients, which leads to great difficulties in quantitative analysis. It is necessary to ensure that the method is specific so that Tween 60 is not interfered by other components, and to ensure that the method has sufficient sensitivity to meet the needs of trace detection. Therefore, it is necessary to develop a method for determining the content of Tween 60 suitable for foams, so as to achieve accurate quantification of Tween 60 in reference preparations.
[0005] The fourth volume of the 2020 edition of the Chinese Pharmacopoeia includes Tween 60 as a pharmaceutical excipient. Its chemical indicators mainly include the determination of hydroxyl value, saponification value, fatty acid composition, etc., but these methods cannot quickly and accurately determine the total amount of Tween 60 in drug preparations.
[0006] Chinese patent CN116297915A (Analysis and identification method of polysorbate excipients) also only provides a method of combining supercritical fluid chromatography and mass spectrometry, which can only identify polysorbate excipients but cannot determine their content.
[0007] There are many methods for determining the content of polysorbate compounds in China, such as UV-visible spectrophotometry, thin layer chromatography, fluorescence derivatization, and gel chromatography-evaporative light scattering detection. However, these methods have the disadvantages of cumbersome operation, long analysis time, poor peak shape, poor sensitivity, no selectivity, and large baseline noise.
[0008] Zhu Wenli et al. (non-patent document 1) established an analytical method for determining the content of excipient Tween 20 in Conbercept ophthalmic injection by reversed-phase high performance liquid chromatography coupled with evaporative light scattering detector. Agilent Poroshell 120SB-C18 (2.7m, 4.6mm×150mm) column was used, and acetonitrile-pure water was used as the mobile phase for gradient elution (0-5min, 5% B; 5-6min, 5% B→60% B; 6-10min, 60% B→80% B; 10-15min, 80% B; 15-15.01min, 80% B→5% B; 15.01-20min, 5% B), with a flow rate of 0.5mL·min -1 , the drift tube temperature of the evaporative light scattering detector was 45 °C, and the atomization pressure was set to 2.8 × 10 5 Pa. Results: The injection amount of Tween 20 was in the range of 1.12-6.72 μg, and it showed a good linear relationship with the chromatographic peak area (R2>0.999); the recoveries of high, medium and low concentration samples were all in the range of 100%±10%. Conclusion: This method can be used for the determination of the content of Tween 20 in Conbercept ophthalmic injection after methodological verification.
[0009] Zheng Ping et al. (non-patent document 2) disclosed a method for determining the content of polysorbate 20 in protein drugs using mixed-mode chromatography and charged aerosol detector. The chromatographic column was Oasis MAX (2.1mm×20mm, 30μm), the column temperature was 30°C, the mobile phase A was 2% (volume fraction) formic acid in isopropanol solution, the mobile phase B was 2% (volume fraction) formic acid in water solution, gradient elution, injection volume 30μL; charged aerosol detector, nebulization chamber temperature 30°C, sampling frequency 5Hz. Results: The linear regression equation of the peak area and concentration of polysorbate 20 was Y=6.643X-0.0445 (r=0.9994), and the linear range was 9.4-188.0mg·mL -1 ; The RSDs of peak area and retention time were 0.66% and 0.04%, respectively; the average recovery was 98.3%; the method quantification limit (S / N=10) was 1.1 mg·mL -1 Conclusion: This instrumental analysis method has good reproducibility and low sample detection limit, and can be used as a method for determining the content of polysorbate 20 in drugs and preparations.
[0010] Tween 20, also known as polyoxyethylene sorbitan monolaurate, polyoxyethylene (20) sorbitan monolaurate, emulsifier T-20, CAS No. 9005-64-5.
[0011] The above-mentioned existing technologies are all methods for determining the content of Tween 20. After consulting the literature, it is found that there are currently no technical documents and reports on the determination of the content of Tween 60. It is necessary to develop a method for quickly, accurately and sensitively determining the content of Tween 60 in pharmaceutical preparations.
[0012] Non-patent literature
[0013] 1) Zhu Wenli, Wu Juan, et al., Determination of the excipient Tween 20 content in Conbercept ophthalmic injection by RP-HPLC-ELSD method [J]. Journal of Pharmaceutical Analysis, 2014, 34(6): 1073.
[0014] 2) Zheng Ping, Liu Luye, Zhang Yanhai, Yuan Bin, Jin Yan, Determination of polysorbate 20 in protein drugs using mixed-mode chromatography and charged aerosol detector [J]. Journal of Pharmaceutical Analysis, 2013, 33(3): 465-469. Summary of the invention
[0015] Technical Problems to be Solved by the Invention
[0016] In view of the fact that there is no report on a general method for determining the content of Tween 60 in pharmaceutical preparations in the prior art, and even less on a method suitable for determining the content of Tween 60 in foams, the purpose of the present invention is to establish a method for detecting Tween 60 in pharmaceutical preparations that is rapid, accurate, highly sensitive, and easy to operate, especially a method for determining the content of Tween 60 in foam preparations. Thus, the content of Tween 60 in the reference preparation can be accurately quantified, ensuring the safety of generic drugs and the quality consistency with the reference preparation.
[0017] Technical means to solve technical problems
[0018] The present invention provides a method for determining the content of Tween 60 in a pharmaceutical preparation, characterized in that a reversed phase liquid chromatography method is used, and the reversed phase liquid chromatography conditions are as follows:
[0019] Chromatographic column: C18 column
[0020] Mobile phase A: water
[0021] Mobile phase B: acetonitrile
[0022] Gradient elution program:
[0023] Time (min) A%(v / v) B%(v / v) 0 95±2 5±2 4 95±2 5±2 6 40±2 60±2 10 20±2 80±2 15 20±2 80±2 15.1 95±2 5±2 20 95±2 5±2
[0024] Detector: CAD detector.
[0025] In the assay method of the present invention, the gradient elution procedure is preferably:
[0026]
[0027]
[0028] In the measuring method of the present invention, the evaporation temperature of the CAD detector is preferably 35±2°C, for example, 33°C, 34°C, 35°C, 36°C, or 37°C.
[0029] In the measurement method of the present invention, the flow rate of the mobile phase is preferably in the range of 1.5±0.2 ml / min, for example, 1.5±0.1 ml / min.
[0030] In the measurement method of the present invention, the column temperature of the chromatographic column is preferably 25°C±3°C, more preferably 25°C±2°C.
[0031] In the determination method of the present invention, during sample analysis, at least two injections of blank solution are injected after each injection of one injection of sample, and the blank solution is acetonitrile or an acetonitrile aqueous solution with an acetonitrile content of more than 70 volume percent.
[0032] In the determination method of the present invention, the reference substance is prepared according to the following method: accurately weigh the reference substance, dissolve it with a diluent and dilute it to prepare a 0.1±0.02 mg / ml reference substance solution.
[0033] In the assay method of the present invention, the test solution is prepared according to the following method: accurately weigh the test sample, dissolve it in a diluent and dilute it to obtain a 0.1±0.02 mg / ml test solution.
[0034] In the determination method of the present invention, the diluent is acetonitrile or an acetonitrile aqueous solution with an acetonitrile content of more than 70% by volume.
[0035] In the assay method of the present invention, the pharmaceutical preparation is a foam.
[0036] In the measuring method of the present invention, the liquid chromatography is HPLC or UPLC.
[0037] Beneficial technical effects
[0038] Beneficial effects of the present invention:
[0039] 1. LC-CAD can be used to accurately quantify Tween 60 in foam preparations and effectively analyze this component in reference preparations.
[0040] 2. This method has simple sample preparation, strong applicability of chromatographic conditions, and is suitable for foam preparations of various concentrations and ratios.
[0041] 3. This method has been systematically verified and meets the basic requirements of the Pharmacopoeia and ICH, providing a new method for the determination of Tween 60 content in foam preparations. BRIEF DESCRIPTION OF THE DRAWINGS
[0042] Figure 1 :Chromatogram under the following chromatographic conditions.
[0043] Figure 2 : Chromatogram under chromatographic condition two.
[0044] Figure 3 :Chromatogram after increasing the test sample concentration under chromatographic condition two.
[0045] Figure 4 : Chromatogram under chromatographic condition three.
[0046] Figure 5 : Chromatogram under chromatographic condition four.
[0047] Figure 6 : Chromatogram of Example 1. DETAILED DESCRIPTION
[0048] definition
[0049] It is to be understood that as used herein, the singular forms "a," "an," "an," and "the" include plural forms unless the context clearly dictates otherwise.
[0050] The terms "above", "below", "within", and "at least" herein include the present number unless the context clearly dictates otherwise.
[0051] When the embodiments are described herein as "comprising", "containing", or "including", other similar embodiments described as "consisting of" and / or "consisting essentially of" are also provided. It should also be understood that when the embodiments are described herein as "consisting essentially of", other similar embodiments described as "consisting of" are also provided.
[0052] The term "and / or" as used herein in phrases such as "A and / or B" is intended to include both A and B; A or B; A (alone); and B (alone). Similarly, the term "and / or" as used in phrases such as "A, B, and / or C" is intended to include each of the following embodiments: A, B, and C; A, B, or C; A or C; A or B; B or C; A and C; A and B; B and C; A (alone); B (alone); and C (alone).
[0053] The "±" used in phrases such as "A±B" herein means all values ranging from AB to A+B. For example, 1.5±0.2 means all values from 1.3 to 1.7 and values within the range of 1.3 to 1.7 after rounding.
[0054] The diluent herein is acetonitrile or an acetonitrile aqueous solution with a high acetonitrile content, such as an acetonitrile aqueous solution with a volume percentage of more than 70%, such as 70%, 75%, 80%, 85%, 90%, 95% or more acetonitrile aqueous solution.
[0055] The blank solution herein is also the diluent, which is acetonitrile or an acetonitrile aqueous solution with a high acetonitrile content, such as an acetonitrile aqueous solution with a volume percentage of more than 70%, such as 70%, 75%, 80%, 85%, 90%, or 95% or more acetonitrile aqueous solution.
[0056] Example
[0057] The present invention is described in detail below with reference to the following examples. The examples provide detailed implementation methods and processes to fully disclose and demonstrate that the invention can be implemented. The examples do not represent limitations on the invention, and the protection scope of the present invention is not limited to the following examples.
[0058] The instruments, reagents, materials, experimental animals, etc. whose sources are not specified in the examples of the specification are purchased through general commercial channels. The experimental methods without specific conditions in the examples of the specification are usually carried out according to the conventional conditions in the field or the conditions recommended by the manufacturer.
[0059] Sample preparation
[0060] Reference substance solution: Accurately weigh an appropriate amount of reference substance Tween 60, dissolve it in a diluent and dilute it to prepare a reference substance solution with a concentration of approximately 0.1 mg / ml.
[0061] Test sample solution: Accurately weigh an appropriate amount of the test sample, place it in a volumetric flask of corresponding volume, add diluent to dissolve and dilute it to prepare a test sample solution containing Tween 60 at a concentration of approximately 0.1 mg / mL.
[0062] The diluent is acetonitrile or an acetonitrile aqueous solution with a high acetonitrile content, such as an acetonitrile aqueous solution with a volume percentage of more than 70%, such as 70%, 75%, 80%, 85%, 90%, 95% or more acetonitrile aqueous solution.
[0063] Chromatographic conditions establishment process
[0064] Optimization of mobile phase and gradient elution conditions
[0065] 1. Chromatographic conditions 1
[0066] Mobile phase: A = water (pure water), B = acetonitrile (CAS No.: 75-05-8, purchased from Sigma-Aldrich)
[0067] 1) Chromatographic parameters:
[0068]
[0069] The chromatogram obtained under the following chromatographic conditions is as follows Figure 1 As shown, the conclusion is: the peak shape is good, but the blank solution has interference at the main peak position of Tween 60, and the chromatographic parameters need to be further optimized. The blank solution is acetonitrile.
[0070] 2. Chromatographic conditions 2
[0071] Optimization scheme a: adjust the elution gradient and running time, and keep other chromatographic parameters unchanged. The adjusted gradient is as follows:
[0072] Time (min) A%(v / v) B%(v / v) 0 95 5 4 95 5 6 40 60 10 20 80 15 20 80 15.1 95 5 20 95 5
[0073] The chromatogram under this parameter is as follows Figure 2 As shown. After increasing the concentration of the test sample, the chromatogram is as follows Figure 3 shown.
[0074] Conclusion: The blank solution (acetonitrile) has no interference at the main peak of Tween 60. To improve the sensitivity of the method, the concentration of the test sample was increased, and the peak shape was still good. However, the problem of sample residue was found during the detection process. The residual impurity peak will affect the subsequent sample determination. Therefore, the method will continue to be optimized.
[0075] 3. Chromatographic condition three: Adjust the gradient to increase the proportion of organic phase to elute the impurity peaks in the test solution, and keep the other chromatographic conditions unchanged.
[0076] Time (min) A%(v / v) B%(v / v) 0 95 5 4 95 5 6 40 60 10 20 80 11 0 100 30 0 100 32 95 5 40 95 5
[0077] The chromatogram under this parameter is as follows Figure 4 Conclusion: The impurity peak still interferes with the next injection of sample.
[0078] 4. Chromatographic Conditions IV
[0079] Try to eliminate interfering peaks by adding blank injections. The chromatogram is as follows: Figure 5 Conclusion: The test results show that the third blank has almost no interference at the main peak, so two blanks are inserted after each test sample to eliminate the influence of the interference peak. The blank solution can be acetonitrile or an acetonitrile aqueous solution with a high acetonitrile content, such as an acetonitrile aqueous solution with a volume percentage of more than 70%, such as 70%, 75%, 80%, 85%, 90%, 95% or more acetonitrile aqueous solution.
[0080] Column selection
[0081] The present invention investigates C18 chromatographic columns from different manufacturers, for example, Poroshell 120EC-C18 chromatographic columns from Agilent Technologies, Hypersil 120EC-C18 chromatographic columns from Thermo Fisher Scientific, TM BDS C18 chromatographic column, and Waters' Xbridge C18 chromatographic column, etc., there is no obvious difference in separation effect between chromatographic columns of different manufacturers, and the present invention finally selects Waters Xbridge C18 chromatographic column.
[0082] After optimizing various conditions, the final technical solution of the present invention is as follows:
[0083] Reference substance solution: Accurately weigh an appropriate amount of reference substance Tween 60, dissolve it in acetonitrile and dilute it to prepare a reference substance solution with a concentration of approximately 0.1 mg / ml.
[0084] Test sample solution: Accurately weigh an appropriate amount of the test sample, place it in a volumetric flask of corresponding volume, add diluent (acetonitrile or acetonitrile aqueous solution with high acetonitrile content) to dissolve and dilute it, and the concentration of Tween 60 in the test sample solution is about 0.1 mg / mL.
[0085] Mobile phase: A = water (pure water), B = acetonitrile (CAS No.: 75-05-8, purchased from Sigma-Aldrich)
[0086] Chromatographic parameters:
[0087]
[0088]
[0089] Example
[0090] The present invention is described in detail below with reference to the following examples. The examples provide detailed implementation methods and processes to fully disclose and demonstrate that the invention can be implemented. The examples do not represent limitations on the invention, and the protection scope of the present invention is not limited to the following examples.
[0091] The instruments, reagents, materials, etc. whose sources are not specified in the examples of the specification are purchased through general commercial channels. The experimental methods without specific conditions in the examples of the specification are usually carried out according to conventional conditions in the art or according to the conditions recommended by the manufacturer.
[0092] Example 1: Determination of Tween 60 in Foam Formulations Using HPLC-CAD
[0093] 1) Solution preparation
[0094] Mobile phase: A-water, B-acetonitrile (CAS No.: 9005-67-8, purchased from Sigma-Aldrich)
[0095] Diluent: acetonitrile.
[0096] Reference solution: Accurately weigh about 25 mg of the auxiliary material Tween 60, place it in a 250 mL volumetric flask, dissolve it with diluent and dilute it to the scale, shake well, and obtain.
[0097] Test sample solution: Accurately weigh about 2 g of the test sample (domestic generic foaming agent, foreign original foaming agent, foreign generic foaming agent), place it in a 50 mL volumetric flask, add appropriate amount of diluent and ultrasonically dissolve it, dilute to the scale, shake well, filter, and take the filtrate.
[0098] 2) Test conditions
[0099] Chromatographic parameters:
[0100]
[0101]
[0102] 3) Test results
[0103] The blank solution (diluent acetonitrile), reference solution and test solution were analyzed by HPLC-CAD, and the obtained chromatogram overlay is shown in the figure below. Figure 6 As shown, the diluent has no interference at the elution point of the target peak (Tween 60).
[0104] The test results of the test products are as follows:
[0105]
[0106] Example 2
[0107] Investigation of the linear range of the test method provided in Example 1
[0108] 1) Linear solution preparation
[0109] Reference substance stock solution: Accurately weigh about 100 mg of the auxiliary material Tween 60, place it in a 50 mL volumetric flask, dissolve it with diluent and dilute it to the scale, shake well, and obtain.
[0110] According to the table below, take the corresponding amount of reference stock solution (Stock STD) into a volumetric flask, add diluent to dilute to the scale, and shake well.
[0111]
[0112]
[0113] 2) Linear solution sample detection
[0114] Take a linear series of standard solutions (L-1, L-2, L-3, L-4, L-5), and inject each solution once. Take the concentration as the abscissa and the peak area as the ordinate to perform linear fitting. The results are shown in the table below.
[0115]
[0116] 3) Conclusion of Linear Investigation
[0117] The test results show that the linear regression equation of Tween 60 is y=8.615x+0.1792, the linear range is 0.06372mg / mL~0.2124mg / mL, the linear correlation coefficient R is 0.9956, and the linear results are good.
[0118] Example 3
[0119] The accuracy and repeatability of the test method provided in Example 1 were investigated.
[0120] (1) Accuracy and repeatability of solution preparation
[0121] The reference substance stock solution is as shown in Example 2, and 6 spiked test substance solutions are prepared according to the following table.
[0122] name Sample weight (g) Volume of reference stock solution (ml) Final volume (ml) SPLB-1 2.0424 5.0 50 SPLB-2 2.0470 5.0 50 SPLB-3 2.0410 5.0 50 SPLB-4 2.0158 5.0 50 SPLB-5 2.0486 5.0 50 SPLB-6 2.0458 5.0 50
[0123] (2) Accuracy / repeatability solution sample testing
[0124] Take the prepared accuracy / repeatability solution and inject it respectively. The results are as follows:
[0125]
[0126] (3) Conclusion of the accuracy / repeatability test: The recovery rates of Tween 60 in the six accuracy / repeatability solutions were between 95.29% and 103.92%, indicating that the Tween 60 content determination method of the present invention has good accuracy, and the RSD is 3.7%, indicating that the repeatability is also good.
[0127] It should be noted that the present invention is not limited to the above implementation modes and examples. The above implementation modes and examples are only examples, and implementation modes that have substantially the same structure as the technical idea and exert the same effect within the scope of the technical solution of the present application are all included in the technical scope of the present application. In addition, within the scope of the subject matter of the present application, various modifications and substitutions of the implementation modes / examples that can be thought of by those skilled in the art, and other methods formed by combining some of the constituent elements in the implementation modes are also included in the scope of the present application, and the scope of protection of the present invention is defined by the attached claims.
Claims
1. A method for determining the content of Tween 60 in a pharmaceutical preparation, characterized in that: Reverse phase liquid chromatography was used, and the reverse phase liquid chromatography conditions were as follows: Chromatographic column: C18 column Mobile phase A: water Mobile phase B: acetonitrile Gradient elution program: Detector: CAD detector.
2. The method according to claim 1, characterized in that The gradient elution procedure is: 。 3. The method according to claim 1 or 2, characterized in that The evaporation temperature of the CAD detector is 35±2°C.
4. The method according to claim 1 or 2, characterized in that: Chromatographic conditions also include: The flow rate of the mobile phase is 1.5 ± 0.2 ml / min, and / or The column temperature of the chromatographic column is 25℃±3℃.
5. The method according to claim 1 or 2, characterized in that: During sample analysis, at least two injections of blank solution are injected after each injection of one injection of sample, wherein the blank solution is acetonitrile or an acetonitrile aqueous solution with an acetonitrile content of more than 70% by volume.
6. The method according to claim 1 or 2, characterized in that: The reference substance was prepared as follows: accurately weighed, dissolved in a diluent and diluted to obtain a 0.1±0.02 mg / ml reference substance solution.
7. The method according to claim 1 or 2, characterized in that: The test solution was prepared as follows: accurately weigh the test sample, dissolve it in a diluent and dilute it to obtain a 0.1 ± 0.02 mg / ml test solution.
8. The method of claim 6 or 7, wherein the diluent is acetonitrile or an acetonitrile aqueous solution having an acetonitrile content of more than 70% by volume.
9. The method according to claim 1 or 2, wherein the pharmaceutical preparation is a foam.
10. The method according to claim 1 or 2, wherein the liquid chromatography is HPLC or UPLC.
Citation Information
Patent Citations
Analysis and identification method of polysorbate auxiliary materials
CN116297915A
